Article Versions Notes

Sveikata A, Liutkauskienė S, Juozaitytė E, Characiejus D, Tamošaitytė L, Šeštakauskas K. An Open-Label Multicenter Safety, Tolerability, and Efficacy Study of Recombinant Granulocyte Colony-Stimulating Factor in the Prevention of Neutropenic Complications in Breast Cancer Patients. Medicina. 2011; 47(8):428. https://doi.org/10.3390/medicina47080064

Sveikata, Audrius, Sigita Liutkauskienė, Elona Juozaitytė, Dainius Characiejus, Laimutė Tamošaitytė, and Kastytis Šeštakauskas. 2011. "An Open-Label Multicenter Safety, Tolerability, and Efficacy Study of Recombinant Granulocyte Colony-Stimulating Factor in the Prevention of Neutropenic Complications in Breast Cancer Patients" Medicina 47, no. 8: 428. https://doi.org/10.3390/medicina47080064

Sveikata, A., Liutkauskienė, S., Juozaitytė, E., Characiejus, D., Tamošaitytė, L., & Šeštakauskas, K. (2011). An Open-Label Multicenter Safety, Tolerability, and Efficacy Study of Recombinant Granulocyte Colony-Stimulating Factor in the Prevention of Neutropenic Complications in Breast Cancer Patients. Medicina, 47(8), 428. https://doi.org/10.3390/medicina47080064